Heleen Aardema

Heleen Aardema is a researcher affiliated with the University of Groningen, focusing on critical care pharmacology and infectious diseases. Her work emphasizes optimizing antibiotic therapies and understanding gut microbiota changes in intensive care unit (ICU) patients. She contributes to interdisciplinary studies involving machine learning for drug concentration predictions and longitudinal cohort analyses of microbial shifts in cardio-surgical patients. Her research aligns with UN Sustainable Development Goals related to good health and well-being (SDG 3).

Key research interests include pharmacokinetics of antibiotics like piperacillin and cefotaxime, clinical decision-making in ICU settings, and the role of microbiota in infection prevention. She has conducted randomized controlled trials comparing drug infusion methods and explored predictive modeling for personalized treatment approaches.

Collaborative efforts span microbiology, cardiology, and data science, aiming to improve infection management strategies in critical care environments. No scientific awards or grants are explicitly listed, but her contributions reflect impactful clinical and translational research.